PDK1 and Miyoshi myopathy: The glycolysis-related enzyme pyruvate dehydrogenase kinase-1 (PDK1) is overexpressed in MM but not in normal tissues, and targeting this with the PDK1 inhibitor dichloroacetate was demonstrated to be an effective method of disrupting glycolysis in MM and inducing apoptosis [12].